Literature DB >> 21909494

The microbial flora associated with oral carcinomas.

Raghavendra Byakodi1, R Krishnappa, Vaishali Keluskar, Anjana Bagewadi, Arvind Shetti.   

Abstract

OBJECTIVE: Changes in the microbial flora on the oral mucosa after cancerous alteration may lead to both local and systemic infections. In this study, we assessed the microbial flora associated with the surfaces of oral squamous cell carcinoma. A comparative evaluation of these microbial contents was made with that of the contralateral healthy mucosa and control (healthy) mucosa. We also assessed the microbial flora from the saliva culture in subjects with oral squamous cell carcinoma and healthy controls. METHOD AND MATERIALS: The case control study was made up of 30 subjects with oral squamous cell carcinoma as the study group; 30 healthy age-, sex-, habit-, and dentition-matched subjects served as the control group. In the study group, microbial samples were collected from the carcinoma site, contralateral healthy mucosa, and saliva, whereas in the control group, samples were collected from the healthy mucosa and saliva. These samples were stored on ice and subsequently transported to the laboratory in 2 mL of thioglycollate transport media, where the microbial cultures were carried out.
RESULTS: Oral squamous cell carcinoma sites harbor significantly more microbial flora (bacteria and yeasts) compared to those of healthy mucosa (control group). The microbial flora predominantly isolated from the carcinoma site were Streptococcus species, Staphylococcus species, Moraxella species, Enterococcus feacalis, Aerobic spore bearers, Klebsiella species, Citrobacter species, Proteus species, Pseudomonas species, and Candida albicans. The median number of colony forming units (CFU)/mL at carcinoma sites (3.85 x 105 CFU/mL) was significantly higher than that of the healthy mucosa (0.571 x 105 CFU/mL; P = .0000, Wilcoxon nonparametric test). Similarly, in saliva of carcinoma subjects, the median number of CFU/mL (2.408 x 105 CFU/mL) was significantly higher than that of saliva in control subjects (0.78 x 105 CFU/mL; P = .0000, Wilcoxon nonparametric test).
CONCLUSION: The present study clearly indicates that the subjects with oral squamous cell carcinoma harbor significantly more microbial flora. Emphasis has to be given to preventing microbial flora in the oral cavity and treating these patients with appropriate antimicrobial agents, thus reducing their morbidity.

Entities:  

Mesh:

Year:  2011        PMID: 21909494

Source DB:  PubMed          Journal:  Quintessence Int        ISSN: 0033-6572            Impact factor:   1.677


  5 in total

Review 1.  Microbiota dysbiosis in select human cancers: Evidence of association and causality.

Authors:  Jie Chen; Jada C Domingue; Cynthia L Sears
Journal:  Semin Immunol       Date:  2017-08-16       Impact factor: 11.130

2.  Oral recipient site infections in reconstructive surgery - impact of the graft itself and the perioperative antibiosis.

Authors:  Matthias Zirk; Artjom Zalesski; Franziska Peters; Matthias Kreppel; Max Zinser; Joachim E Zöller
Journal:  Clin Oral Investig       Date:  2019-10-23       Impact factor: 3.573

3.  Discovery and validation of potential bacterial biomarkers for lung cancer.

Authors:  Xinmin Yan; Mingxia Yang; Juan Liu; Ruichen Gao; Jihong Hu; Jiong Li; Lijun Zhang; Yujia Shi; Hongrong Guo; Jinluo Cheng; Miriam Razi; Shen Pang; Xiaowei Yu; Shen Hu
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

4.  Microbial diversity similarities in periodontal pockets and atheromatous plaques of cardiovascular disease patients.

Authors:  Wagner Serra e Silva Filho; Renato C V Casarin; Eduardo L Nicolela; Humberto M Passos; Antônio W Sallum; Reginaldo B Gonçalves
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

Review 5.  The controversial role of Enterococcus faecalis in colorectal cancer.

Authors:  Carolina Vieira de Almeida; Antonio Taddei; Amedeo Amedei
Journal:  Therap Adv Gastroenterol       Date:  2018-06-26       Impact factor: 4.409

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.